title: Arylsulfatase-A in umbilical cord blood: gestational age and mode of delivery do not influence enzyme activity.
abstract: The possibility of using umbilical cord blood for transplantation in several enzyme deficiencies has received increasing attention because of the availability of cord blood, the reduced incidence of post-transplantation complications, such as graft-versus-host disease and the possible accomplishment of good corrective results following transplantation, even in cases of greater HLA disparity. The use of hematopoietic stem cells from unrelated donors is even more highly recommended for the treatment of inherited enzyme deficiencies, because it might reduce the risk of the transplanted cells originating from a carrier of the defect, which might have an inadequate corrective ability. Our study was designed to elucidate whether the gestational age and mode of delivery influences the arylsulfatase-A activity in the umbilical cord blood. Enzyme activities proved to be similar in the four populations studied (full-term normal spontaneous vaginal delivery, full-term caesarean section, preterm normal spontaneous vaginal delivery and preterm caesarean section). Therefore, umbilical cord blood samples seem to be suitable for transplantation in metachromatic leukodystrophy, regardless of gestational age and mode of delivery. Moreover, our results are the first published data on normal values for arylsulfatase-A activity in human umbilical cord blood.
authors.affiliation: Mullikin Medical Centers, Artesia, CA, USA.
authors.forename: G D
authors.initials: GD
authors.lastname: Georgeson
authors.forename: B J
authors.initials: BJ
authors.lastname: Szöny
authors.forename: K
authors.initials: K
authors.lastname: Streitman
authors.forename: E
authors.initials: E
authors.lastname: Sallay
authors.forename: A
authors.initials: A
authors.lastname: Kovács
authors.forename: L
authors.initials: L
authors.lastname: Kovács
authors.forename: A
authors.initials: A
authors.lastname: László
mesh_terms: D002553:Cerebroside-Sulfatase / Q000097:blood*; D002585:Cesarean Section / Q000379:methods; D036861:Delivery, Obstetric / Q000379:methods*; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D005312:Fetal Blood / Q000201:enzymology*; D005865:Gestational Age; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D007231:Infant, Newborn; D007233:Infant, Postmature / Q000097:blood; D007234:Infant, Premature / Q000097:blood; D007966:Leukodystrophy, Metachromatic / Q000601:surgery; D011247:Pregnancy; D011262:Pregnancy Trimester, Second / Q000097:blood; D011263:Pregnancy Trimester, Third / Q000097:blood / Q000378:metabolism; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000201:enzymology
chemical_list: D002553:Cerebroside-Sulfatase